Bloodborne Pathogen Exposure Profile (HIV, HBV, HCV)
Also known as: BBP, Needlestick
Use
This profile is intended to support evaluation following potential exposure to bloodborne pathogens (e.g., needle stick and other sharps injuries, mucous membrane exposure and skin exposure). This profile includes assays for the detection of HBV, HCV and HIV.
Special Instructions
HIV p24 Antigen/Antibody With Reflex to Confirmation [083935] requires a dedicated, unopened, gel-barrier tube or red-top tube sent directly to the testing facility. Patients should be asked about biotin supplementation and advised to stop taking it at least 72 hours before sample collection. Additional charges or CPT codes may apply if reflex testing is performed.
Limitations
Negative results do not rule out infection as analytes may be undetectable in early infection. The assays in this panel have not been FDA cleared or approved for the screening of blood or plasma donors, or for cadaveric specimens. Performance characteristics of some tests included in this panel have not been established for immunocompromised or immunosuppressed patients or patients less than 2 years of age.
Methodology
Immunoassay
Biomarkers
LOINC Codes
- 56888-1
- 5196-1
- 22322-2
- 13952-7
- 77202-0
- 56850-1
- 13955-0
Result Turnaround Time
1-4 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
5 mL
Minimum Volume
3 mL
Container
Gel-barrier tube
Collection Instructions
Usual blood collection technique
Patient Preparation
Patients should be cautioned to stop biotin consumption at least 72 hours prior to collection.
Causes for Rejection
Gross hemolysis; gross lipemia; samples containing particulate matter or exhibiting obvious microbial contamination
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | 14 days |